The impact of reducing dose frequency on health outcomes
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 25 (8) , 2307-2335
- https://doi.org/10.1016/s0149-2918(03)80222-9
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhalerAnnals of Allergy, Asthma & Immunology, 2001
- Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthmaJournal of Allergy and Clinical Immunology, 2000
- Enhancing Patient Compliance in the ElderlyDrugs & Aging, 1998
- Issues in Patient ComplianceDrugs, 1997
- Nonadherence in Asthmatic Patients: Is there a Solution to the Problem ?Annals of Allergy, Asthma & Immunology, 1997
- Comparison of once daily and twice daily nisoldipine as monotherapy in essential hypertensionControlled Clinical Trials, 1996
- BudesonidePharmacoEconomics, 1995
- Translating Safety, Efficacy and Compliance into Economic Value for Controlled Release Dosage FormsPharmacoEconomics, 1994
- Fixed Combination Drug TherapyDrugs, 1982
- Slow release oxprenolol in angina pectoris: Study comparing oxprenolol, once daily, with propranolol, four times dailyThe American Journal of Cardiology, 1981